Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study

INTRODUCTION: The mainstay systemic treatment for non-oncogenic addictive advanced stage non-small cell lung cancer is chemotherapy. Anti-angiogenic agents are additive compounds that enhance disease control and lead to improvement of overall survival benefit. Recently PD-(L)1 blockage, a checkpoint...

Descripción completa

Detalles Bibliográficos
Autores principales: Korphaisarn, Krittiya, Danchaivijitr, Pongwut, Reungwetwattana, Thanyanan, Chewaskulyong, Busayamas, Thongthieang, Luangyot, Chindaprasirt, Jarin, Maneenil, Kunlatida, Sathitruangsak, Chirawadee, Vinayanuwattikun, Chanida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117590/
https://www.ncbi.nlm.nih.gov/pubmed/33996532
http://dx.doi.org/10.3389/fonc.2021.572740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117590/
https://www.ncbi.nlm.nih.gov/pubmed/33996532
http://dx.doi.org/10.3389/fonc.2021.572740

Ejemplares similares